Evidence map›Paper›PMID 22532574›Full record

SynthesisHuman molecular genetics2012

Identification of a novel percent mammographic density locus at 12q24.

Kristen N Stevens, Sara Lindstrom, Christopher G Scott, Deborah Thompson, Thomas A Sellers, Xianshu Wang, Alice Wang, Elizabeth Atkinson, David N Rider, Jeanette E Eckel-Passow and 44 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Human molecular genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Heritability of mammographic breast density.Quantitative imaging in medicine and surgery · 2020
    Article
  9. Article
  10. Article
  11. Genetic variation in sensitivity to estrogens and breast cancer risk.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors.

Kristen N StevensDepartment of Health Sciences Research, Mayo Clinic, Charlton 6-239, 200 First St. SW, Rochester, MN 55905, USA.
Sara Lindstrom
Christopher G Scott
Deborah Thompson
Thomas A Sellers
Xianshu Wang
Alice Wang
Elizabeth Atkinson
David N Rider
Jeanette E Eckel-Passow
Jajini S Varghese
Tina Audley
Judith Brown
Jean Leyland
Robert N Luben
Ruth M L Warren
Ruth J F Loos
Nicholas J Wareham
Jingmei Li
Per Hall
Jianjun Liu
Louise Eriksson
Kamila Czene
Janet E Olson
V Shane Pankratz
Zachary Fredericksen
Robert B Diasio
Adam M Lee
John A Heit
Mariza DeAndrade
Ellen L Goode
Robert A Vierkant
Julie M Cunningham
Sebastian M Armasu
Richard Weinshilboum
Brooke L Fridley
Anthony Batzler
James N Ingle
Norman F Boyd
Andrew D Paterson
Johanna Rommens
Lisa J Martin
John L Hopper
Melissa C Southey
Jennifer Stone
Carmel Apicella
Peter Kraft
Susan E Hankinson
Aditi Hazra
David J Hunter
Douglas F Easton
Fergus J Couch
Rulla M Tamimi
Celine M Vachon

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Zhenkun Lou · 2009 to 2026
$37.0M
Variation in Receptor Tyrosine Kinases and Breast Cancer RiskP50CA089393 · NCI · DANA-FARBER CANCER INSTITUTE · PI HARRIS, LYNDSAY NORINE · 2000 to 2009
$28.8M
Pharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WANG, LIEWEI, WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8M
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORTR01CA049449 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI HANKINSON, SUSAN E · 1989 to 2008
$11.3M
Haplotype-Based Genome Screen for Ovarian Cancer LociR01CA114343 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2007 to 2011
$7.5M
Molecular Epidemiology of NHL and CLLR01CA092153 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2003 to 2012
$6.7M
BIOCHEMICAL MARKERS IN THE NURSES HEALTH STUDY COHORTU01CA049449 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI HANKINSON, SUSAN E · 1995 to 2013
$5.4M
Mayo Cancer Genetic Epidemiology Training ProgramR25CA092049 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M., VACHON, CELINE M · 2001 to 2018
$5.3M
Genetic epidemiology of cell division regulation in breast cancerR01CA122340 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2007 to 2011
$3.0M
Identifying Genes for Mammographic Breast DensityR01CA128931 · NCI · MAYO CLINIC ROCHESTER · PI VACHON, CELINE M · 2008 to 2012
$2.7M
British Heart FoundationCancer Research UK 10118Cancer Research UK 11022Cancer Research UK C1287Cancer Research UK C1287/A10118Cancer Research UK C8459Department of HealthMedical Research Council G0701863Medical Research Council MC_U106179471NCBDD CDC HHS DD000235NCBDD CDC HHS U01 DD000235NCI NIH HHS CA049449NCI NIH HHS CA087969NCI NIH HHS CA089393NCI NIH HHS CA131332NCI NIH HHS CA92153NCI NIH HHS P01 CA087969NCI NIH HHS P50 CA089393NCI NIH HHS P50 CA116201NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA049449NCI NIH HHS R01 CA092153NCI NIH HHS R01 CA114343NCI NIH HHS R01 CA122340NCI NIH HHS R01 CA122443NCI NIH HHS R01 CA128931NCI NIH HHS R01 CA131332NCI NIH HHS R01 CA58427NCI NIH HHS R25 CA092049NCI NIH HHS U01 CA049449NHGRI NIH HHS HG04735NHGRI NIH HHS U01 HG004735NHLBI NIH HHS HL83131NIGMS NIH HHS U19 GM061388NIGMS NIH HHS U19 GM61388
6 · The paper itself

Abstract

Percent mammographic density adjusted for age and body mass index (BMI) is one of the strongest risk factors for breast cancer and has a heritable component that remains largely unidentified. We performed a three-stage genome-wide association study (GWAS) of percent mammographic density to identify novel genetic loci associated with this trait. In stage 1, we combined three GWASs of percent density comprised of 1241 women from studies at the Mayo Clinic and identified the top 48 loci (99 single nucleotide polymorphisms). We attempted replication of these loci in 7018 women from seven additional studies (stage 2). The meta-analysis of stage 1 and 2 data identified a novel locus, rs1265507 on 12q24, associated with percent density, adjusting for age and BMI (P = 4.43 × 10(-8)). We refined the 12q24 locus with 459 additional variants (stage 3) in a combined analysis of all three stages (n = 10 377) and confirmed that rs1265507 has the strongest association in the 12q24 region (P = 1.03 × 10(-8)). Rs1265507 is located between the genes TBX5 and TBX3, which are members of the phylogenetically conserved T-box gene family and encode transcription factors involved in developmental regulation. Understanding the mechanism underlying this association will provide insight into the genetics of breast tissue composition.

Indexed as

AgedBreast NeoplasmsChromosomes, Human, Pair 12Cohort StudiesFemaleGenome-Wide Association StudyHumansMammary Glands, HumanMammographyMiddle AgedPolymorphism, Single NucleotideRisk FactorsT-Box Domain ProteinsUnited StatesWhite PeopleT-Box Domain ProteinsT-box transcription factor 5TBX3 protein, human

Identifiers

PMID22532574
PMCPMC3384385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.